Loading
Latest filing published 13 Jun 2017 for Acasti Pharma Inc., €5,956.
No signal scores available.
Pierre Fitzgibbon appears in our data through filings on Acasti Pharma Inc. shares, published by SEDI. Between 21 February 2017 and 13 June 2017, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 3 purchases worth €11k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €4,220.
Most recently, on 13 June 2017, the filings show an open-market purchase worth €5,956 in Acasti Pharma Inc. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations